OBJECTIVE: To conduct a full genome search for genes potentially influencing two related phenotypes: body mass index (BMI, kg/m 2 ) and percent body fat (PBF) from bioelectric impedance in men and women. DESIGN: A total of 3383 participants, 1348 men and 2035 women; recruitment was initiated with hypertensive sibpairs and expanded to first-degree relatives in a multicenter study of hypertension genetics. MEASUREMENTS: Genotypes for 387 highly polymorphic markers spaced to provide a 10 cM map (CHLC-8) were generated by the NHLBI Mammalian Genotyping Service (Marshfield, WI, USA). Quantitative trait loci for obesity phenotypes, BMI and PBF, were examined with a variance components method using SOLAR, adjusting for hypertensive status, ethnicity, center, age, age 2 , sex, and age 2 Â sex. As we detected a significant genotype-by-sex interaction in initial models and because of the importance of sex effects in the expression of these phenotypes, models thereafter were stratified by sex. No genotype-byethnicity interactions were found. RESULTS: A QTL influencing PBF in women was detected on chromosome12q (12q24.3-12q24.32, maximum empirical LOD score ¼ 3.8); a QTL influencing this phenotype in men was found on chromosome 15q (15q25.3, maximum empirical LOD score ¼ 3.0). These QTLs were detected in African-American and white women (12q) and men (15q). QTLs influencing both BMI and PBF were found over a broad region on chromosome 3 in men. QTLs on chromosomes 3 and 12 were found in the combined sample of men and women, but with weaker significance. CONCLUSION: The locations with highest LOD scores have been previously reported for obesity phenotypes, indicating that at least two genomic regions influence obesity-related traits. Furthermore, our results indicate the importance of considering context-dependent effects in the search for obesity QTLs.
Introduction
Obesity is associated with a variety of adverse health outcomes, 1 yet the prevalence of obesity has increased in the US among both adults and children, and in several other countries, since the 1960s. [2] [3] [4] [5] [6] Since the genetic composition of the population has not changed substantially in the previous four decades, these secular trends are likely due to environmental factors, especially changes in dietary and physical activity habits. 7 Individual susceptibility to obesity is thought to be determined by interactions between an individual's genetic make-up and the environment, thus the increased prevalence of obesity most likely reflects the expression of susceptibility loci in the context of secular trends in environmental factors.
There are various lines of evidence supporting a genetic effect on obesity. Studies have shown that a family history of obesity increases the individual risk of becoming obese; some studies have suggested that the risk of becoming obese for a first-degree relative of an obese individual is up to eighttimes the population risk. 8, 9 Between 40 and 70% of the variation in obesity-related phenotypes appears to be heritable. 10 Segregation analyses have shown evidence of genes with relatively large effects on body fat and body mass. 11 Recent reports of genome scans on body mass index (BMI) and percent body fat (PBF) using various sampling schemes have found linkage to regions on several chromosomes in diverse populations, including Americans of European, Mexican, and African descent; Pima Indians; Old Order Amish; several European populations; children; and patients with obstructive sleep apnea, a common obesity comorbidity. Results of these genome scans for phenotypes related to obesity vary by study, and may be confounded by differences in the populations studied and their respective cultural and environmental differences. This report describes an analysis of linkage for two obesityrelated phenotypes, BMI and PBF from bioelectric impedance, and analysis of interactions of genotype with ethnicity and sex. The study population consists of participants in the HyperGEN study, and includes African-American and white sibpairs selected for hypertension, a common obesity comorbidity, and their first-degree relatives. Regions showing evidence for QTLs by linkage analysis are reported for these quantitative obesity-related phenotypes.
Methods
The Hypertension Genetic Epidemiology Network (Hyper-GEN 33 ), one of four networks in the NHLBI Family Blood Pressure Program, 34 involves four field centers from the population-based NHLBI Family Heart Study (FHS 35 ), and a fifth field center in Birmingham, AL, was added to achieve a sample size of at least half African-American. This report is based on 1751 white and 2241 African-American relative pairs recruited by the HyperGEN network. The original populations recruited for FHS and thus HyperGEN were defined and enumerated from the Framingham Heart Study, the Atherosclerosis Risk in Communities (ARIC) Study in Minneapolis and Forsyth County, NC, and the Utah Health Family Tree Study. For white participants, the FHS centers had sufficient families from which to recruit the needed numbers of hypertensive sibpairs. The sample of African-Americans in FHS was limited and thus recruitment of this group in Birmingham and Forsyth County was mainly from the community.
The present report includes participants from a sample of severely and mildly hypertensive sibships. All available, affected siblings were recruited from each eligible sibship, with a minimum number of two hypertensive sibs required to complete a sibship. Exclusion criteria for HyperGEN included age of hypertension onset over 60 y; evidence of secondary hypertension (eg, hypertension secondary to primary kidney disease); hypertension during pregnancy only (for hypertensive sibs); or type 1 diabetes mellitus (insulin therapy prior to age 21 y). First-degree relatives of the hypertensive sibs were also recruited, including offspring if they were 18 y of age or older and all possible parents. Family structure data are contained in Table 1 . There are more women and female-relative groups in the sample. A random sample of age-matched persons from the same base populations was recruited and used to calculate ethnicityspecific marker allele frequencies.
The random sample from the FHS centers was selected from the source populations. Biologically unrelated individuals, mostly spousal pairs, were recruited from these FHS families without regard to hypertension status. The Forsyth County and Alabama centers recruited their random samples of African-Americans using similar strategies: mailings to randomly selected addresses from a computerized database of Department of Motor Vehicle listings of area residents.
We excluded from analysis 10 individuals who were part of a monozygotic twin pair. In addition, six individuals were excluded from analyses because of the small number of nonAfrican-Americans included from one site. To reduce skewness in the phenotypic data, five outliers (any observation more than 4 standard deviations from the mean and at least 1 standard deviation from the nearest data point) were also excluded, as well as two participants with negative values for body fat. After these exclusions were made, there were 3383 participants with genotypic data, 2035 women and 1348 men.
All measurements were performed by trained and certified technicians using standard protocols and calibrated instruments. Body Three 10 ml vacutainer tubes with EDTA were drawn from each participant, centrifuged, and the cells shipped to the HyperGEN central biochemistry laboratory for processing. Genomic DNA was isolated from whole blood using standard procedures. Genotyping was provided by the NHLBI Mammalian Genotyping Service (Marshfield, WI, USA). Details on gel preparation and PCR conditions are available from the Mammalian Genotyping Service website (http://marshmed. org/genetics). The CHLC screening set 8 was used, which includes 387 microsatellite markers approximately equally spaced (approximately 10 cM distance) throughout the genome. We calculated the average marker heterozygosity for these data to be 0.76. Analyses and assignment of the marker alleles were carried out using computerized algorithms. Relationship status among the purportedly full sibs was tested using ASPEX, a likelihood-based method. Only confirmed full sibs or other first-degree relatives were used in the linkage analysis.
We tested for linkage of obesity-related phenotypes with a variance component model applied to extended family data using STR loci with a 10 cM genome-wide map in the combined sample and in each sex separately. An extension of the strategy developed by Amos 37 was used to estimate the genetic variance attributable to a specific chromosomal location. 38 This approach is based on specifying the expected genetic covariance between arbitrary relatives as a function of the identity-by-descent (IBD) relationships at a given marker locus.
Using a variance component model, 39 we also tested the null hypothesis that the additive genetic variance due to a QTL (s 2 ) equals zero (no linkage) by comparing the likelihood of this restricted model with that of a model in which s 2 is estimated. The difference between the two log10 likelihoods produces a LOD score that is the equivalent of the classical LOD score of linkage analysis. Twice the difference in loge likelihoods of these models yields a test statistic that is asymptomatically distributed as a 1/2 : 1/2 mixture of a w 2 variable and a point mass at zero. 40 Extensive simulation suggests that the likelihood ratio test yields expected nominal P-values for a wide variety of reasonable trait distributions. 41 The kurtosis values for PBF were À0.58, 0.22, 0.11, and for BMI were 0.83, 1.03, and 0.31 for the combined sexes, males, and females, respectively. This quantitative trait linkage method was implemented in SOLAR, 38 which determines whether genetic variation at a specific chromosomal location can explain the variation in the phenotype. 42 The use of the variance component approach requires an estimate of the IBD matrix. The small size of our families allowed us to compute exact conditional probabilities using the Lander-Green algorithm as implemented in MERLIN 43 using allele frequencies from founders and calculated separately in the African-American and white samples. The IBD probabilities computed by MERLIN were then combined into a single set of multipoint IBD files in the SOLAR format using the program Mer2sol (http://taxa.epi.umn.edu/mer2-sol/) developed by one of us (MBM). The advantage of this approach is that it provides accurate IBD estimation using appropriate allele frequencies, allowing linkage analyses in the two ethnic groups separately, as well as of both ethnic groups in a combined analysis.
Each phenotype was adjusted for hypertension status, use, and number of antihypertensive medications, ethnicity, center, age, age 2 , sex, and age 2 Â sex within the context of the linkage model in SOLAR. As use and number of antihypertensive medications did not significantly improve the model, all further analyses were conducted without these covariates.
We tested for linkage to BMI and PBF using a variance component linkage model extended to include genotype-bysex interaction at a QTL. [44] [45] [46] The expected genetic covariance between a male and female relative pair i, j is defined as
where f is the coefficient of kinship between the two individuals, r G (M,F) is the genetic correlation between the expressions of the trait in the two sexes, and s gM and s gF are the genetic standard deviations for males and females, p q is the probability that individuals i and j are IBD at a quantitative trait locus which is linked to a genetic marker locus, and s qM and s qF are the markerspecific genetic standard deviations for males and females, respectively. In the absence of additive genotype-by-sex interaction (ie, the null hypothesis), the genetic correlation between male and female relative pairs should be one (r G(M,F) ¼ 1.0) and male and female genetic standard deviations will be equivalent (s gM ¼ s gF ). Conversely, if there is additive genotype-by-sex interaction, the genetic correlation between the sexes will be significantly o1.0 and/or the genetic standard deviations will not be equal between the sexes. The likelihood of a model including a genotype-by-sex interaction was compared with the likelihoods of restricted models in which such interactions were excluded using a likelihood-ratio test. [47] [48] [49] Secondly, we added the marker-specific To verify our major linkage findings, we calculated the empirical distribution of the LOD scores under the assumption of multivariate normality, using 10 000 replicates and simulation methods incorporated into SOLAR. 38 We used the empirical distribution of the simulated LOD scores to assign percentiles to each replicate, and calculated an expected test statistic on the basis of the percentile. SOLAR produces a correction constant by regressing the expected LOD scores on the observed simulated LOD scores, which we used to determine an empirical LOD score [empirical LOD Score ¼ Observed LOD score Â Correction constant]. 50 
Results
The average age at examination for the entire study population was approximately 53 y in both men and women (Table 2) , with whites older than African-Americans in both sexes. Mean BMI in all groups was near or in the obese range (BMI Z30.0 kg/m 2 ), and was highest in African-American women, who also had the highest prevalence of obesity. Average PBF was higher in women than men. The prevalence of PBF440 was more common in women of both ethnic groups than in men and was more common in AfricanAmericans. The prevalence of hypertension was approximately 75% in all but African-American women, in whom it was 81%.
In the combined sample, we detected significant differences in mean BMI by sex (Po0.0000001), age Â sex (Po0.002), hypertension status (Po0.0000001), and ethnicity/center (Pr0.10) and retained these covariates in our models to eliminate any confounding and focus on the decomposition of variance to detect possible QTLs underlying BMI variability. For PBF, we detected significant differences in mean PBF by sex (Po0.0000001), age Â sex (Po0.04), hypertension status (Po0.0000001), and ethnicity/center (Pr0.10) and also retained these covariates in our models to eliminate confounding. In sex-specific analyses, we also controlled for age, hypertension status, ethnicity, and center. After accounting for covariates, there was strong residual heritability of both BMI and PBF in the combined sample, men, and women (Table 3) . Residual heritability was higher in men (81%) than in women (61%) for BMI. Residual heritability was similar for PBF (70 and 63%, respectively). 
Genome scan of body fatness: HyperGEN CE Lewis et al
We found evidence for gene-environment interactions with sex but not for ethnicity for both PBF and BMI. For both traits, the model in which the genetic correlation between men and women (r g(M,F) ¼ 1.0) was constrained to 1.0 was significantly lower than the general model in which this correlation was estimated (r g 0.5470.11 and r g 0.4370.10, both Po0.001, for PBF and BMI, respectively). The implication is that there are some distinct additive genetic effects on PBF and BMI in men and women. In contrast, the fit of the model in which the male and female genetic standard deviations were constrained to be equal (s g,M 2 ¼ s g,F 2 ) was not significantly worse (PZ0.05) than the fit of the general model in which such interaction was allowed. The implication is that the magnitude of the genetic effects is not different in men and women.
The maximum adjusted multipoint genome-wide LOD scores for both phenotypes in the combined sexes, men, and women, for all peaks with an LOD score of 1.7 or more (suggestive of linkage 51 ) are given in Table 4 . The maximum empirical LOD score observed was 3.8 for PBF in women on chromosome 12 at map location 146 cM (flanking markers D12S395 and D12S2078, Figure 1) ; an empirical LOD of 1.5 was also found for BMI (data not shown). This QTL on Chromosome 12q was detected in both African-American (empirical LOD of 2.4) and white women (empirical LOD of 1.5).
In men, the maximum empirical LOD score was 3.0 for PBF on chromosome 15 at 84 cM (nearest marker D15S655, Figure 2 ); for BMI there was a peak with an empirical LOD of 0.9 at this region. This QTL on Chromosome 15q was detected in both African-American (empirical LOD of 1.1) and white men (empirical LOD of 1.8).
Both PBF and BMI demonstrated a maximum empirical LOD score of 2.6 and 2.3, respectively, on chromosome 3 (138 cM) in men, and there were other QTLs for each phenotype with LOD scores of 1.7 or higher on this chromosome from 102 to 200 cM (Figure 3a and b) . One QTL was found on chromosome 18, at 35 cM for body fat in men. Other locations on chromosome 7 for PBF in men, and on chromosomes 2 and 21 for PBF, and 11 for BMI in women Genome scan of body fatness: HyperGEN CE Lewis et al were found to have LOD scores of 1.7 or more, but were not consistent across phenotypes.
Discussion
We report here results of a genome scan for closely related obesity phenotypes in African-American and white men and women originating from a study of sibpairs with hypertension and their first-degree relatives. In this study, we found evidence for gene-environment interactions with sex but not ethnicity. While it is possible that our observations of sex-specific QTLs may result from a combination of type I or II errors, differences in the expression of genes influencing variation in BMI or PBF by sex are biologically plausible and supported by several lines of evidence. Sexual dimorphism in body fat content and its distribution has long been recognized in both humans and animals. In general, males are larger, weigh more, and tend to have a centralized/ abdominal pattern of fat accumulation. In contrast, females are smaller, have greater total body fat, 52 and less accumulation of central fat. 53 These variations are likely to be influenced to some extent by the milieu of endogenous sex hormones, as suggested by the development of more malespecific fat distribution patterns in post-menopausal women. It is possible that the hormonal milieu specifically influences regulation of QTLs influencing adiposity generating the pattern of sex-specific QTLs as reported in the present study. Interactions with sex have been reported previously from studies of Finnish 54 and Norwegian 55 twins, from a segregation analysis of the Québec Family Study, 56 and from studies of inbred rat strains that have found sex-specific QTLs for obesity. 57 Sexual dimorphism has also been observed in such characteristics as leptin concentration and ob gene expression; 58 expression of hormone-sensitive lipase and lipoprotein lipase in subcutaneous abdominal fat in response to weight loss; 59 fat deposition in PPAR-a knockout mice; 60 the effect of variants in the leptin receptor, 61 and in the leptin gene itself. 62 While it is important to determine whether sex-specific QTLs for adiposity replicate in other studies, our results suggest that sex may have important environmental influences and that our ability to identify relevant genes may be improved by incorporating such effects into our linkage models. In our study, the highest empirical LOD scores were for a QTL influencing PBF in women detected on chromosome12q (12q24.3-12q24.32) and influencing PBF in men on chromosome 15q (15q25.3). There were empirical LOD scores for a BMI of 1.5 on chromosome 12 in women and 0.9 for chromosome 15 in men. A broad region of chromosome 3 demonstrated linkage to both phenotypes in men, while there were two QTLs located on chromosome 18 demonstrating linkage to BMI (18 cM, empirical LOD ¼ 1.4) and PBF (35 cM, empirical LOD ¼ 1.7) in men. The P-values for the QTL-specific genotype-by-sex interaction were o0.008 for chromosome 12 and o0.00002 for chromosome 15 for PBF, and o0.008 for chromosome 3 for BMI.
Previous genome scans for obesity phenotypes have had divergent results, reporting at least suggestive linkage on most chromosomes in at least one analysis. However, the sample sizes, phenotypic characterizations, populations, and ascertainment schemes vary considerably across published reports. Early reports indicated relatively consistent findings for 10p from three studies of US European American, French, and German cohorts. Genome scan of body fatness: HyperGEN CE Lewis et al subcutaneous fat in participants of the Quebec Family Study (Table 5) . Two plausible candidate genes are located in the 17 cM (1 LOD unit drop) support interval, scavenger receptor type B class 1 (SRB1) and acetyl-CoA carboxylase-beta (ACACB). SRB1 is a key component in the reverse cholesterol transport pathway where it binds HDL-C with high affinity and is involved in the selective transfer of lipids from it. 68, 69 SRB1 is expressed primarily in liver and nonplacental steroidogenic tissues and mediates selective cholesterol uptake. Previous studies have found associations between SRB1 gene variants and BMI in a white population, 70 BMI with a gender interaction, 71 obesity, 72 and HDL and triglycerides in individuals with coronary artery disease. 73 The study by Perez-Martinez 71 is particularly relevant as it lends support to our sex-specific linkage findings in this region. The ACACB gene is thought to control fatty acid oxidation in muscle tissue, by means of the ability of malonyl-CoA to inhibit carnitine palmitoyl transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. Ha et al 74 reported the complete amino-acid sequence and unique features of ACC-beta, which is expressed primarily in heart and skeletal muscles. 74, 75 ACACB is important for the regulation of fat oxidation in rodent muscle (eg Alam and Saggerson
76
) and mouse knockout models have a normal lifespan, a higher fatty acid oxidation rate, and lower amounts of fat. 77 The ACACB gene has also been investigated with regard to fat mass, glucose sensitivity, and insulin. 78, 79 One plausible candidate gene in the 12 cM I-LOD unit drop support interval for the 15q linkage signal is perilipin (PLIN), a hormonally-regulated phospho-protein that encircles the lipid storage droplet in adipocytes. 80 It is the major cellular A-kinase substrate in adipocytes. Studies using knockout mice have demonstrated a major role for PLIN in adipose lipid metabolism and suggested PLIN as a potential target for obesity management. 81 At least one and possibly several QTLs for BMI and fat mass in men were localized to chromosome 3, spanning approximately from 102 to 200 cM. Although the broad signal region of linkage support is difficult to interpret, evidence consistent with linkage was found for BMI on 3q27 (empirical LOD 2.8 at marker D3S2427), through use of the sample combining the sexes. The support for linkage on chromosome 3 between 191 and 200 cM is a notable replication of a region of the genome that has been localized in several studies of adiposity-related phenotypes, 3q27. 22, 26, 29, 64 In addition to the QTLs on chromosomes 12, 15, and 3, we found several regions with suggestive evidence for linkage (LOD scores Z1.9) on chromosomes 2, 7, 11, 18, and 21. Of these locations, all have been detected (based on varying criteria) in other genome screens of adiposity phenotypes (Table 5 ). While we believe our findings are corroborated by those of others, a large number of QTLs for obesity have been reported and thus one could argue that a 'replication' may be found for any QTL reported. However, our genome scan can Genome scan of body fatness: HyperGEN CE Lewis et al be viewed as a hypothesis-generating exercise in which we observe an interesting LOD score at a particular location, which is significant even judging by the most conservative criteria. Corroboration with other studies can then be considered as testing a specific hypothesis, that there is a QTL at this location, not at any location, and that hypothesis can be evaluated using standard statistical criteria, that is, alpha ¼ 0.05 as the critical level. In this context, other studies with LOD scores of 0.834 or better (corresponding to alpha o0.05) can be considered as corroborating evidence of linkage at this location. The more studies we identify with such corroborating evidence, the less likely it is that these are a series of type I errors. We found some consistency between the obesity-related phenotypes BMI and PBF for the chromosome 12 and 15 regions in women and men, respectively, with the LOD scores for BMI not achieving those of body fat. While the BMI and body fat phenotypes are highly correlated, the bioimpedance measures and BMI may have slightly different contaminants and errors, and may explain the differences we see in our results. Finally, however, we did find consistent findings for both phenotypes on chromosome 3q in men.
The families were selected for hypertension, a phenotype correlated with obesity; however, we have not used an ascertainment correction in these analyses. First, this is not likely a strong ascertainment effect because enriching our sample for hypertension-related susceptibility alleles would not be expected to strongly influence the distribution of adiposity QTLs. Nonetheless, neglecting a modest ascertainment effect would only result in some loss of information and a reduced power for our analysis, making the results presented here conservative, without any increase in the type I error rate. 85 While recognizing the possibility of locus heterogeneity when combining ethnic groups, our main analysis combined them and analyzed by sex, given our findings of those geneenvironment interactions. We calculated mIBD sharing in MERLIN using ethnicity-specific allele frequencies for the sex-specific analysis and adjusted for ethnicity. We also employed linkage analysis separately in the African-American and white samples and found that the major QTLs were detected on 12q and 15 q in both ethnic groups in women and men, respectively. Thus, this finding lends validity to the combined ethnicity findings.
In conclusion, we found significant linkage results for QTLs related to obesity phenotypes on chromosome 12q in women, and 15q and 3q in men. QTLs in these regions have been reported by others and there are plausible positional candidate genes, such as adiponectin. Thus, these results may warrant further investigation as potentially relevant to the development of obesity in humans. HyperGEN plans to follow up the chromosome 12 signal in women. Future studies should also consider the possibility of context-dependent effects in the pathogenesis of obesity.
